Interleukin-1 receptor antagonist modulates inflammation and scarring after ligament injury

References

• Chamberlain CS, Crowley E, Vanderby R. The spatio-temporal dynamics of ligament healing. Wound Repair Regen 2009;17:206–15
   PubMed Web of Science ®Google Scholar
• Frank C, Schachar N, Dittrich D. Natural history of healing in the repaired medial collateral ligament. J Orthopaedic Res 1983;1:179–88
   PubMed Web of Science ®Google Scholar
• Levenson SM, Geever EF, Crowley LV, Oates JF 3rd, Berard CW, Rosen H. The healing of rat skin wounds. Ann Surg 1965;161:293–308
   PubMed Web of Science ®Google Scholar
• Lin TW, Cardenas L, Soslowsky LJ. Biomechanics of tendon injury and repair. J Biomech 2004;37:865–77
   PubMed Web of Science ®Google Scholar
• Chamberlain CS, Brounts SH, Sterken DG, Rolnick KI, Baer GS, Vanderby R. Gene profiling of the rat medial collateral ligament during early healing using microarray analysis. J Appl Physiol 2011;111:552–65
   PubMed Web of Science ®Google Scholar
• Chamberlain CS, Crowley EM, Kobayashi H, Eliceiri KW, Vanderby R. Quantification of collagen organization and extracellular matrix factors within the healing ligament. Microscopy Microanal 2011;17:779–87
   PubMed Web of Science ®Google Scholar
• Chamberlain CS, Leiferman EM, Frisch KE, Brickson SL, Murphy WL, Baer GS, Vanderby R. The influence of interleukin-1 receptor antagonist on ligament healing. PloS One. 2013;in press
   Google Scholar
• Bosschaerts T, Guilliams M, Stijlemans B, Morias Y, Engel D, Tacke F, Herin M, De Baetselier P, Beschin A. Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling. PLoS Pathog 2010;6:e1001045
   Google Scholar
• Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. TN/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003;19:59–70
   PubMed Web of Science ®Google Scholar
• Nathan C, Ding AH. Nonresolving inflammation. Cell 2010;140:871–82
   PubMed Web of Science ®Google Scholar
• Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004;4:583–94
   PubMed Web of Science ®Google Scholar
• Xiao W, Hong H, Kawakami Y, Lowell CA, Kawakami T. Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5. J Clin Invest 2008;118:924–34
   Google Scholar
• Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010;11:889–96
   PubMed Web of Science ®Google Scholar
• Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exper Med 2007;204:1057–69
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Blocking interleukin-1 receptors. Int J Clin Lab Res 1994;24:61–79
   PubMedGoogle Scholar
• Thomay AA, Daley JM, Sabo E, Worth PJ, Shelton LJ, Harty MW, Reichner JS, Albina JE. Disruption of interleukin-1 signaling improves the quality of wound healing. Am J Pathol 2009;174:2129–36
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095–147
   PubMed Web of Science ®Google Scholar
• Kim DH, Lee SH, Kim KT, Yu SD. Association of interleukin-1 receptor antagonist gene polymorphism with response to conservative treatment of lumbar herniated nucleus pulposus. Spine 2010;35:1527–31
   PubMed Web of Science ®Google Scholar
• Hirsch E, Irikura VM, Paul SM, Hirsh D. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 1996;93:11008–13
   PubMed Web of Science ®Google Scholar
• Nicklin MJ, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exper Med 2000;191:303–12
   PubMed Web of Science ®Google Scholar
• Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, Ikuse T, Asano M, Iwakura Y. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exper Med 2000;191:313–20
   PubMed Web of Science ®Google Scholar
• Chevalier X, Goupille P, Beaulieu AD, Burch FX, Conrozier T, Loeuille D, Kivitz AJ, Silver D, Kiefer P, Zhou L, Bevirt T, Appleton B. Results from a double blind, placebo-controlled, multicenter trial of a single intra-articular injection of anakinra (kineret (R)) in patients with osteoarthritis of the knee. Arthritis Rheum 2005;52:S507–S
   Web of Science ®Google Scholar
• Chevalier X, Goupille P, Beaulieu AD, Burch FX, Bensen WG, Conrozier T, Loeuille D, Kivitz AJ, Silver D, Appleton BE. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009;61:344–52
   PubMed Web of Science ®Google Scholar
• Goupille P, Mulleman D, Chevalier X. Is interleukin-1 a good target for therapeutic intervention in intervertebral disc degeneration: lessons from the osteoarthritic experience. Arthritis Res Therapy 2007;9:110–11
   PubMedGoogle Scholar
• Provenzano PP, Heisey D, Hayashi K, Lakes R, Vanderby R. Subfailure damage in ligament: a structural and cellular evaluation. J Appl Physiol 2002;92:362–71
   PubMed Web of Science ®Google Scholar
• Provenzano PP, Martinez DA, Grindeland RE, Dwyer KW, Turner J, Vailas AC, Vanderby R. Hindlimb unloading alters ligament healing. J Appl Physiol 2003;94:314–24
   PubMed Web of Science ®Google Scholar
• Provenzano PP, Rueden CT, Trier SM, Yan L, Ponik SM, Inman DR, Keely PJ, Eliceiri KW. Nonlinear optical imaging and spectral-lifetime computational analysis of endogenous and exogenous fluorophores in breast cancer. J Biomed Opt 2008;13:031220
   Web of Science ®Google Scholar
• Yamada J, Dana MR, Sotozono C, Kinoshita S. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exper Eye Res 2003;76:161–7
   PubMed Web of Science ®Google Scholar
• Hu Y, Liang D, Li X, Liu HH, Zhang X, Zheng M, Dill D, Shi X, Qiao Y, Yeomans D, Carvalho B, Angst MS, Clark JD, Peltz G. The role of interleukin-1 in wound biology. Part I: Murine in silico and in vitro experimental analysis. Anesthesia Analgesia 2010;111:1525–33
   PubMed Web of Science ®Google Scholar
• Hu Y, Liang D, Li X, Liu HH, Zhang X, Zheng M, Dill D, Shi X, Qiao Y, Yeomans D, Carvalho B, Angst MS, Clark JD, Peltz G. The role of interleukin-1 in wound biology. Part II: In vivo and human translational studies. Anesthesia Analgesia 2010;111:1534–42
   PubMed Web of Science ®Google Scholar
• Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23–35
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002;23:549–55
   PubMed Web of Science ®Google Scholar
• Na YR, Yoon YN, Son DI, Seok SH. Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in Murine breast cancer model. PloS One 2013;8:e63451
   PubMed Web of Science ®Google Scholar
• Jensen KT, Rabago DP, Best TM, Patterson JJ, Vanderby R, Jr. Early inflammatory response of knee ligaments to prolotherapy in a rat model. J Orthopaedic Res 2008;26:816–23
   PubMed Web of Science ®Google Scholar